KeratoScoop (Rebecca's blog)

The Effect of Topical Pranoprofen 0.1% on the Clinical Evaluation and Conjunctival HLA-DR Expression in Dry Eyes.

PURPOSE:
To investigate the effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival human leukocyte antigen II (HLA-DR) expression in dry eyes.
METHODS:
Sixty patients with dry eyes were randomized to 2 groups. Patients in group 1 received topical pranoprofen 0.1% plus topical sodium hyaluronate 0.1%; and patients in group 2 received

...

Pranoprofen = an NSAID (non-steroidal anti-inflammatory). They're comparing sodium hyaluronate drops vs. SH plus this NSAID vs. SH plus FML (corticosteroid).

I sometimes find it interesting (sad too but won't dwell on that right now) what they use to cause corneal disease or dry eye in animal dry eye studies. They used to use PRK to induce limbal stem cell deficiency... now BAK (BAC, benzalkonium chloride) to induce dry eye. Of course this BAK percentage is exponentially higher than ...